FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0

CUSIP: 33938JAB2

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Debt / NOTE 3.375% 5/0
Market price (% of par)
87.31%
Total 13F principal
$167,336,758
Principal change
-$10,331,242
Total reported market value
$146,294,481
Number of holders
23
Value change
-$9,012,249
Number of buys
8
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 33938JAB2?
CUSIP 33938JAB2 identifies 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 as of Q2 2019

As of 30 Jun 2019, FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 was held by 23 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $167,336,758 in principal (par value) of the bond. The largest 10 bondholders included Allianz Asset Management GmbH, ZAZOVE ASSOCIATES LLC, SILVERBACK ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, ADVENT CAPITAL MANAGEMENT /DE/, WELLS FARGO & COMPANY/MN, CALAMOS ADVISORS LLC, Linden Advisors LP, PALISADE CAPITAL MANAGEMENT LLC/NJ, and OAKTREE CAPITAL MANAGEMENT LP. This page lists 23 institutional bondholders reporting positions for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.